# Hyster-Yale, Inc.: overview

HY · NYSE · CIK 1173514 · [Industrials](/sectors/industrials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/hy.md) · [Financials](/companies/hy/financials.md) · [Filings](/companies/hy/filings.md) · [Insiders](/companies/hy/insiders.md)

Latest reported revenue: [$0](/filings/0001173514-26-000202.md) for Q2 FY2026, three months to 2026-06-30, from the 10-Q filed Aug 4, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001173514-26-000202).

## Last eight quarters

| Line item | Unit | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [0.0](/filings/0001173514-25-000126.md) | [4,308 d](/filings/0001173514-26-000049.md) | [0.0](/filings/0001173514-26-000114.md) | [0.0](/filings/0001173514-26-000202.md) | [0.0](/filings/0001173514-25-000126.md) | [3,769 d](/filings/0001173514-26-000049.md) | [0.0](/filings/0001173514-26-000114.md) | [0.0](/filings/0001173514-26-000202.md) |
| Gross margin | % | not reported | [4.8% d](/filings/0001173514-26-000049.md) | not reported | not reported | not reported | [3.5% d](/filings/0001173514-26-000049.md) | not reported | not reported |
| Operating margin | % | not reported | [0.7% d](/filings/0001173514-26-000049.md) | not reported | not reported | not reported | [(1.0%) d](/filings/0001173514-26-000049.md) | not reported | not reported |
| Net margin | % | not reported | [0.2% d](/filings/0001173514-26-000049.md) | not reported | not reported | not reported | [(1.4%) d](/filings/0001173514-26-000049.md) | not reported | not reported |
| Diluted EPS | $ per share | [0.97](/filings/0001173514-25-000126.md) | not reported | [0.48](/filings/0001173514-26-000114.md) | [(0.79)](/filings/0001173514-26-000202.md) | [(0.13)](/filings/0001173514-25-000126.md) | not reported | [(1.71)](/filings/0001173514-26-000114.md) | [(1.76)](/filings/0001173514-26-000202.md) |
| Free cash flow | $m | [59.9 d](/filings/0001173514-25-000126.md) | [62.8 d](/filings/0001173514-26-000049.md) | [(47.0)](/filings/0001173514-26-000114.md) | [15.1 d](/filings/0001173514-26-000202.md) | [22.6 d](/filings/0001173514-25-000126.md) | [32.9 d](/filings/0001173514-26-000049.md) | [(42.7)](/filings/0001173514-26-000114.md) | [2.0 d](/filings/0001173514-26-000202.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax; Revenue: us-gaap:Revenues. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 9-month figure less the 6-month figure; 12-month figure less the 9-month figure; 6-month figure less the 3-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [3,076](/filings/0001173514-24-000014.md) | [3,548](/filings/0001173514-25-000015.md) | [4,118](/filings/0001173514-26-000049.md) | [4,308](/filings/0001173514-26-000049.md) | [3,769](/filings/0001173514-26-000049.md) |
| Gross margin | % | [11.8%](/filings/0001173514-24-000014.md) | [12.2%](/filings/0001173514-25-000015.md) | [19.1%](/filings/0001173514-26-000049.md) | [20.8%](/filings/0001173514-26-000049.md) | [16.8%](/filings/0001173514-26-000049.md) |
| Operating margin | % | [(5.0%)](/filings/0001173514-24-000014.md) | [(1.1%)](/filings/0001173514-25-000015.md) | [5.1%](/filings/0001173514-26-000049.md) | [5.7%](/filings/0001173514-26-000049.md) | [(0.6%)](/filings/0001173514-26-000049.md) |
| Net margin | % | [(5.6%)](/filings/0001173514-24-000014.md) | [(2.1%)](/filings/0001173514-25-000015.md) | [3.1%](/filings/0001173514-26-000049.md) | [3.3%](/filings/0001173514-26-000049.md) | [(1.6%)](/filings/0001173514-26-000049.md) |
| Diluted EPS | $ per share | [(10.29)](/filings/0001173514-24-000014.md) | [(4.38)](/filings/0001173514-25-000015.md) | [7.24](/filings/0001173514-26-000049.md) | [8.04](/filings/0001173514-26-000049.md) | [(3.40)](/filings/0001173514-26-000049.md) |
| Free cash flow | $m | [(298)](/filings/0001173514-24-000014.md) | [11.8](/filings/0001173514-25-000015.md) | [115](/filings/0001173514-26-000049.md) | [123](/filings/0001173514-26-000049.md) | [23.6](/filings/0001173514-26-000049.md) |

- Revenue. XBRL Revenue: us-gaap:Revenues.
- Gross margin (gross profit / revenue). XBRL Gross profit: us-gaap:GrossProfit; Revenue: us-gaap:Revenues.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:Revenues.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:Revenues.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/hy/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $32.9m | 937,868 |  | Added +29,356 |
| [GAMCO INVESTORS, INC. ET AL](/funds/807249.md) | 2026-06-30 | $27.6m | 788,021 |  | Reduced −23,036 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $17.4m | 495,257 |  | Reduced −92,426 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $16.4m | 467,943 |  | Reduced −7,848 |
| [DEPRINCE RACE & ZOLLO INC](/funds/1008894.md) | 2026-06-30 | $14.5m | 413,935 |  | Added +146,456 |
| [AMERICAN CENTURY COMPANIES INC](/funds/748054.md) | 2026-06-30 | $14.1m | 401,588 |  | Reduced −11,293 |
| [VALUEWORKS LLC](/funds/1282189.md) | 2026-06-30 | $13.9m | 397,633 |  | Added +2,250 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $11.6m | 330,858 |  | Added +21,954 |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $10.4m | 296,593 |  | Reduced −630 |
| [Russell Investments Group, Ltd.](/funds/1692234.md) | 2026-06-30 | $7.7m | 220,524 |  | Added +61,938 |

## Recent filings

[All 7,543 filings](/companies/hy/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-15 | 20:37 ET | [8-K](/filings/0001173514-26-000233.md) | 5.02 Departure or appointment of officers or directors | 0001173514-26-000233 |
| 2026-08-06 | 20:03 ET | [8-K](/filings/0001173514-26-000213.md) | 5.02 Departure or appointment of officers or directors | 0001173514-26-000213 |
| 2026-08-05 | 20:33 ET | [8-K](/filings/0001173514-26-000209.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001173514-26-000209 |
| 2026-08-04 | 21:01 ET | [8-K](/filings/0001173514-26-000203.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001173514-26-000203 |
| 2026-08-04 | 21:01 ET | [10-Q](/filings/0001173514-26-000202.md) | Quarterly report, period 2026-06-30 | 0001173514-26-000202 |
| 2026-08-04 | 21:00 ET | [8-K](/filings/0001173514-26-000201.md) | 2.02 Results of operations; 9.01 Financial statements and exhibits | 0001173514-26-000201 |
| 2026-05-14 | 18:52 ET | [8-K](/filings/0001173514-26-000125.md) | 5.07 Shareholder vote results | 0001173514-26-000125 |
| 2026-05-06 | 20:33 ET | [8-K](/filings/0001173514-26-000119.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001173514-26-000119 |
| 2026-05-05 | 20:47 ET | [8-K](/filings/0001173514-26-000115.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001173514-26-000115 |
| 2026-05-05 | 20:46 ET | [10-Q](/filings/0001173514-26-000114.md) | Quarterly report, period 2026-03-31 | 0001173514-26-000114 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001173514-26-000049.md), filed Mar 3, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, is open for forecasts until the first results filing for it is accepted by EDGAR. Results are due by \[object Promise\]. [Forecast this quarter](/leagues/2026q3/targets/6d1008a7-c555-4080-a788-83c87b0fff3b)

## About the filer

- CIK: 1173514
- Tickers: HY
- Exchange: NYSE
- SIC code: 3537 Industrial Trucks, Tractors, Trailors & Stackers
- State of incorporation: DE
- Filer category: Accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 24, 2026, 15:35 ET. No prices; not investment advice.